Posts by DAY Vision

[vc_row][vc_column][vc_column_text]Leading experts discussed clinical results and cost effectiveness of intra-operative detection of cancer on the tissue margin during lumpectomy for breast cancer—Vienna, Austria, March 22, 2012- Dilon Devices, the manufacturer of the MarginProbe® System, held a satellite symposium featuring discussions with experts in the field of breast cancer regarding the treatment of women with early…

[vc_row][vc_column][vc_column_text]4 Million Covered Lives Provided Access to MarginProbe Caesarea, Israel, March 12, 2012. Dilon announced today that Clalit, Israel’s largest HMO, with a network of 8 surgical centers and 4 million insured, has informed Dilon that it has approved the MarginProbe System for use throughout the Clalit network. The MarginProbe System provides surgeons the ability…

[vc_row][vc_column][vc_column_text] MarginProbe use reduces re-excision surgeries in patients with diffuse disease Framingham, MA, December 8, 2011- An analysis of the MarginProbe pivotal study for patients with ductal carcinoma in situ (DCIS) and invasive lobular carcinoma (ILC) were presented today during the 2011 CTRC-AACR San Antonio Breast Cancer Symposium. The results were presented by Dr. Susan…

[vc_row][vc_column][vc_column_text] MarginProbe use reduces re-excision surgeries while conserving tissue Framingham, MA, December 7, 2011- Data from the MarginProbe system pivotal study were presented today during the 2011 CTRC-AACR San Antonio Breast Cancer Symposium. The results were presented by Dr. Freya Schnabel, Director of Breast Surgery, NYU Langone Medical Center, New York University, New York, New…